Autologous stem cell transplant in patients with chronic peripheral arterial insufficiency of the lower limbs
DOI:
https://doi.org/10.5281/zenodo.12421541Keywords:
autologous transplantation, ; hemorrhagic shock, : postnatal careAbstract
Introduction: lower limb ischemia is a chronic and common disease whose usual cause is metabolic diseases such as diabetes and atherosclerosis.
Objective: to evaluate the results of autologous transplantation of adult stem cells from bone marrow in patients with chronic peripheral arterial insufficiency of the lower limbs.
Methods: pre-experimental study, at the “Dr. Antonio Luaces Iraola”, from February 2016 to February 2017. The universe consisted of 57 patients who attended the angiology service in the indicated period and the sample consisted of 20 patients who met the inclusion criteria. The patients received treatment with Hebervital® for four days and the autograft was performed through periarterial intramuscular injections of plasma stem cell concentrates. The variables under study were: age, sex, affected vascular sector, claudication distance and ankle-brachial index every three months, up to one year.
Results: the majority of patients were between 50 and 59 years old (40 %), of which 30 % were male. High blood pressure and smoking were the main risk factors found. An increase in the distance from claudication was found in the clinical evolution at 12 months and a more favorable hemodynamic response was obtained after autologous stem cell transplantation.
Conclusions: clinical and hemodynamic improvement was observed 12 months after treatment, which prevented the appearance of critical ischemia in the patients, demonstrating its therapeutic usefulness.
Downloads
References
Lecouturier J, Scott J, Rousseau N, Stansby G, Sims A, Allen J, et al. Peripheral arterial disease diagnosis and management in primary care: a qualitative study. BJGP Open [Internet]. 2019 [citado 7 Feb 2022];3(3):[aprox. 9 p.]. Disponible en: https://bjgpopen.org/content/bjgpoa/3/3/bjgpopen19X101659.full.pdf
Núñez-Rojas G, Lozada-Martinez ID, Bolaño-Romero MP, Ramírez-Barakat E. Isquemia Arterial Aguda De Las Extremidades: ¿cómo Abordarla? Rev. Colomb. Cir [Internet]. 2020 [citado 12 Feb 2022];35(1):100-7. Disponible en: http://www.scielo.org.co/pdf/rcci/v35n1/2619-6107-rcci-35-01-00100.pdf
Martínez-Díaz Y, Fernández-Quintana LC, Cabrera-Zamora JL, Almeida-Hernández L. Calidad de vida en pacientes con enfermedad arterial periférica de miembros inferiores en estadios iniciales. Rev Cubana Angiol Cir Vasc [Internet]. Jun 2018 [citado 7 Feb 2022];19(1):17-7. Disponible en: http://scielo.sld.cu/pdf/ang/v19n1/ang03118.pdf
Martínez-Garrido R, Montano-Iglesias E, de Armas-López G, Pérez-Montiel D. Aplicación de la terapia regenerativa en la enfermedad arterial periférica y el pie diabético isquémico. Rev Cubana Angiología Cirugía Vascular [Internet]. 2019 [citado 16 Feb 2022];20(2):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1682-00372019000200004&script=sci_arttext&tlng=en
Feito-Castex TR, Arce-González MA, Medina-LLamosa PD, Bustillo-Santandreu MJ, García-Seco FV, Perurena-LLamosa C. Caracterización de los pacientes con enfermedad arterial periférica, tratados con células mononucleares autólogas. Rev Cubana Angiol Cir Vasc [Internet]. Ago 2020 [citado 15 Feb 2022];21(2):[aprox 16 p.]. Disponible en: http://scielo.sld.cu/pdf/ang/v21n2/1682-0037-ang-21-02-e91.pdf
Yanishi K, Shoji K, Fujioka A, Hori Y, Yukawa A, Matoba S. Impact of therapeutic angiogenesis using autologous bone marrow-derived mononuclear cell implantation in patients with no-option critical limb ischemia. Ann Vas Dis [Internet]. 2020 [citado 12 Feb 2022];13(1):13-22. Disponible en: https://www.jstage.jst.go.jp/article/avd/13/1/13_ra.20-00002/_pdf
Cooke JP, Meng S. Vascular regeneration in peripheral artery disease. Arteriosclerosis, Thrombosis Vascular Biol [Internet]. 2020 [citado 12 Feb 2022];40(7):1627-34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357605/pdf/nihms-1593955.pdf
Hernández-Ramírez P, Alfonso-Simón A, Aparicio-Suárez JL, Artaza-Sanz H, Baganet-Cobas A, Blanco-Díaz Á, et al. Experiencia cubana con el uso terapéutico de células madre adultas. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2011 [citado 10 Mar 2021];27(1):139-63. Disponible en: http://scielo.sld.cu/pdf/hih/v27n1/hih12111.pdf
Roque-Pérez L, Alfonso-Alfonso Y, Plaín-Pazos C. Aplicaciones de las células madre en la angiología cubana. Universidad Médica Pinareña [Internet]. 2018 [citado 15 Jul 2022];14(3):[aprox. 12 p.]. Disponible en: http://www.revgaleno.sld.cu/index.php/ump/article/view/298/html
Bustos-Araya S, Montenegro-Matamoros Y, Swirgsde-Baltodano C, Trigueros-Hernández D, Vargas-González R, Mora-Román JJ. Obtención de células madre mesenquimales y participación de estas en la modulación de la respuesta inmune. Tecnología en Marcha [Internet]. 2018 [citado 15 Jul 2022];31(3):29-40. Disponible en: https://www.scielo.sa.cr/pdf/tem/v31n3/0379-3982-tem-31-03-29.pdf
Modi J, Menzie-Suderam J, Xu H, Trujillo P, Medley K, Marshall ML, et al. Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model. J Biome Sci [Internet]. 2020 [citado 22 Feb 2022];27(1):[aprox. 19 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943893/pdf/12929_2019_Article_597.pdf
Fontaine R, Kim M, Kieny R. Die chirurgische behandlung der peripheren durchblutungstörungen. Helvetia Chirurgica Acta.1954; 5: 199-233.
Rutherford RB. Vascular Surgery. 4ta ed. Philadelphia: WB Saunders Company; 1995.
Ares AM, Cendán M, Garrote A, González C, Raña CD, Rojo V, et al. Procedimiento de determinación del índice tobillo-brazo con doppler arterial [Internet]. Galicia: Servicio Gallego de Salud; 2020 [citado 20 Feb 2022]. Disponible en: https://extranet.sergas.es/catpb/Docs/cas/Publicaciones/Docs/AtEspecializada/PDF-2858-es.pdf
Lema-Verdía L, Balboa-Barreiroa V, Couceiro-Sánchez E, González-Martín C, Pértega-Díaz S, Seoane-Pillado T, et. al. Enfermedad arterial periférica en pacientes trasplantados renales. Validez del cuestionario de Edimburgo para el diagnóstico de enfermedad. Rev Nefrol Dial Traspl [Internet]. 2021 [citado 20 Feb 2022;41(2):100-2. Disponible en: https://www.revistarenal.org.ar/index.php/rndt/article/view/646/1124
Negrín-Valdés T, Rodríguez-Jiménez AE, Fardales-Rodríguez R, Castellanos-Gallo LA, Meneses-Jiménez JC, López-Callejas MA. El índice tobillo-brazo como predictor de enfermedad coronaria multivaso en pacientes con síndrome coronario agudo y enfermedad arterial periférica. Rev Finlay [Internet]. Sep 2020 [citado 20 Feb 2022];10(3):209-21. Disponible en: http://scielo.sld.cu/pdf/rf/v10n3/2221-2434-rf-10-03-209.pdf
Firnhaber JM, Powell CS. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment. Am Fam Physician [Internet]. 2019 [citado 22 Feb 2022];99(6):362-69. Disponible en: https://www.aafp.org/dam/brand/aafp/pubs/afp/issues/2019/0315/p362.pdf
Shabani-Varaki D, Gargiulo GD, Penkala S, Breen PP. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non invasive diagnostic methods. BioMed Eng Online [Internet]. 2018 [citado 22 Feb 2022];17:61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948740/pdf/12938_2018_Article_494.pdf
Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013. Helsinki: 18ª Asamblea Mundial; 1964 [citado 22 Feb 2022]. Disponible en: http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf
Ortiz-Peña Y, Rodríguez-Casas E. Distancia de claudicación e índice tobillo-brazo en pacientes con insuficiencia arterial tratados con células madre. Rev Cubana Angiol Cir Vasc [Internet]. 2021 [citado 20 Feb 2022];22(2):[aprox. 14 p.]. Disponible en: http://scielo.sld.cu/pdf/ang/v22n2/1682-0037-ang-22-02-e127.pdf
Barnés-Domínguez J, Aguirre-Aguirre M, Triana-Mantilla M, Arpajón-Peña Y. Caracterización de los pacientes con enfermedades vasculares periféricas fallecidos en un período de cuatro años. Rev Cubana Angiol Cirugía Vascular [Internet]. 2022 [citado 18 Jun 2022];23(1):[aprox. 12 p.]. Disponible en: https://revangiologia.sld.cu/index.php/ang/article/view/190/354
Kondo T, Nakano Y, Adachi S, Murohara T. Effects of tobacco smoking on cardiovascular disease. Circ J [Internet]. 2019 [citado 12 Jun 2022];83(10):1980-85. Disponible en: https://www.jstage.jst.go.jp/article/circj/83/10/83_CJ-19-0323/_pdf
Zaid M, Miura K, Okayama A, Nakagawa H, Sakata K, Saitoh S, et al. Associations of high-density lipoprotein particle and high-density lipoprotein cholesterol with alcohol intake, smoking, and body mass index. Circ J [Internet]. 2018 [citado 22 Feb 2022]; 82:2557-65. Disponible en: https://www.jstage.jst.go.jp/article/circj/82/10/82_CJ-18-0341/_pdf
PAD Guideline Writing Grou. ESVM Guideline on peripheral arterial disease. Vasa [Internet]. 2019 [citado 22 Feb 2022];48(Supplement 102):[aprox. 79 p.]. Disponible en: https://discovery.dundee.ac.uk/ws/files/41755642/0301_1526_a000834.pdf
Hernández-Ramírez P, Artaza-Sánz H, Aparicio-Suárez JL, Cruz-Tamayo F, Díaz-Díaz AJ, Fernández-Delgado N, et al. Impact of the regenerative medicine in Angiology. Cuban experience. Rev Cubana Angiol Cir Vasc [Internet]. 2017 [citado 2 Feb 2022];18(1):3-18. Disponible en: http://scielo.sld.cu/pdf/ang/v18n1/ang02117.pdf
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jorge Luis Carrera Martínez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
